A Model of Insulin Resistance in Mice, Born to Diabetic Pregnancy, Is Associated with Alterations of Transcription-Related Genes in Pancreas and Epididymal Adipose Tissue by Yessoufou, Akadiri et al.
Hindawi Publishing Corporation
Journal of Obesity
Volume 2011, Article ID 654967, 11 pages
doi:10.1155/2011/654967
Research Article
AModel of InsulinResistance in Mice,
BorntoDiabeticPregnancy,IsAssociatedwith
Alterations ofTranscription-RelatedGenesinPancreas and
EpididymalAdipose Tissue
AkadiriYessoufou,1,2,3 Kabirou Moutairou,2 andNaimAkhtar Khan1
1Faculty of Life Sciences, University of Bourgogne, UPRES EA 4183 Lipides et Signalisation Cellulaire,
6 Boulevard Gabriel, 21000 Dijon, France
2Laboratory of Cell Biology and Physiology, Department of Biochemistry and Cellular Biology, Faculty of Sciences and Techniques,
University of Abomey-Calavi and Institute of Biomedical and Applied Sciences (ISBA), 01 BP 918 Cotonou, Benin
3Centre for Integrative Genomics, University of Lausanne, Bˆ atiment G´ enopode, 5` e Etage, 1015 Lausanne, Switzerland
Correspondence should be addressed to Akadiri Yessoufou, akadiri.yessoufou@unil.ch
Received 7 June 2010; Accepted 30 August 2010
Academic Editor: Francesco Saverio Papadia
Copyright © 2011 Akadiri Yessoufou et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Objective. This study is conducted on a model of insulin-resistant (IR) mice born to dams which were rendered diabetic by the
administration of streptozotocin. Methods. Adult IR and control oﬀspring were selected and we determined the mRNA expression
of transcription factors known to modulate pancreatic and adipose tissue activities and inﬂammation. Results. We observed that
serum insulin increased, and the mRNA of insulin gene transcription factors, Pdx-1, Nkx6.1 and Maf-A, were upregulated in IR
mice pancreas. Besides, their pancreatic functional capacity seemed to be exhausted as evidenced by low expression of pancreatic
Glut2 and glucokinase mRNA. Though IR oﬀspring exhibited reduced epididymal adipose tissue, their adipocytes seemed to
be diﬀerentiated into macrophage-like cells, as they exhibited upregulated CD14 and CD68 antigens, generally expressed by
macrophages. However, there was no peripheral macrophages inﬁltration into epididymal adipose tissue, as the expression of
F4/80, a true macrophage marker, was undetectable. Furthermore, the expression of IL-6, TNF-α and TLR-2, key players of
insulin resistance, was upregulated in the adipose tissue of IR oﬀspring. Conclusion. Insulin resistant state in mice, born to diabetic
pregnancy, alters the expression of function-related genes in pancreas and epididymal adipose tissue and these oﬀspring are prone
to develop metabolic syndrome.
1.Introduction
Hyperglycemia, related to insulin resistance, is due to a
decrease in peripheral glucose uptake, and to an increase in
hepatic glucose production [1]. In order to induce insulin
resistance, most of the investigators have adopted a strategy
in which they feed the rodents with high-fat diets [2, 3].
However, this dietary intervention is not well standardized,
and the high-fat-induced phenotype varies distinctly among
diﬀerent studies [3]. It is obvious that appropriate animal
models are crucial to study the pathogenesis and therapy
of this complex metabolic disorder. From a scientiﬁc and
an ethical point of view, it is reasonable to obtain a disease
model which should resemble to the pathogenesis in human
beings.
In our laboratory, we have developed a model of insulin
resistanceinmacrosomicratsborntostreptozotocin-(STZ-)
induced diabetic dams [4, 5]. These macrosomic oﬀspring
of diabetic dams were hyperglycemic, hyperinsulinemic, and
they exhibited high serum and liver lipid levels during
adulthood. Recently, we have also developed a model of
insulin resistance in mice born to the STZ-induced diabetic
animals [6]. The pups and their diabetic mothers were fed
the standard laboratory chow. These oﬀspring developed2 Journal of Obesity
a marked hyperinsulinemia, hyperglycemia, and insulin
resistanceatadulthood[6].Inthepresentreport,weassessed
the pancreatic β-cell functions by determining the mRNA
levels of Glut2 and glucokinase. We also examined the
expression of some major insulin gene transcription factors
like pancreatic and duodenal homeobox- (Pdx-) 1, NK6
transcription factor related-locus-1 (Nkx6.1), and Maf-A
[7, 8]. Nkx6.1 is important for the terminal diﬀerentiation of
β-cells[8]andisknowntoinﬂuenceglucose-inducedinsulin
secretion [9]. Pdx-1 regulates the transcription of insulin,
glucokinase, and islet amyloid polypeptide [7, 8]. Moreover,
Pdx-1 and Maf-A can exert their positive actions separately
onthepromoterandtheireﬀectsareadditive[10].Therefore,
we determined the expression of pancreatic mRNA of these
transcription factors in order to respond to the question
whethertheyareinvolvedintheβ-celladaptationinresponse
to insulin resistance.
Because adipokines, secreted by adipose tissue, play
crucial role in the onset of type II diabetes and obe-
sity [11], we determined the mRNA encoding for leptin
and adiponectin in epididymal adipose tissue. Moreover,
macrophages have been shown to inﬁltrate several organs,
including adipose tissue, during inﬂammatory processes
[12]. We, therefore, investigated the expression of mRNA of
CD14, CD68, and F4/80 antigens in the epididymal adipose
tissue of these animals. CD14 has been shown to bind
to lipopolysaccharide (LPS) which interacts with Toll-like
receptors (TLR) [13], and this spurred us to examine the
expression of TLR-2 mRNA in epididymal adipose tissue.
The mRNA expression of tumour necrosis factor- (TNF-)
α and interleukin- (IL-) 6 was determined as these agents
are also known to be secreted in adipose tissue [14]. In
order to shed light whether T cells inﬁltrate the adipose
tissue of insulin-resistant (IR) mice, we also investigated the
mRNAexpression ofTcellreceptor-alpha (TCRα),regulated
on activation of normal T cell expressed and secreted
(RANTES) and its receptor CCR-5 in the epididymal adipose
tissue.
All the aforementioned parameters were studied in adult
controlandIRmicewhichwere,respectively,thedescendents
of control and diabetic dams, since the rationale of the
present study is to explore the metabolic consequences of a
pathologic model of insulin resistance of in utero exposure to
hyperglycemia, that is, diabetic pregnancy.
2.MaterialsandMethods
2.1. Animals and Design. The study was performed on wild
type C57BL/6J mice (Charles River, Les Oncins, France)
at age of 3 months. The insulin-resistant (IR) oﬀspring
of diabetic mice were obtained as described elsewhere
[6]. Brieﬂy, after mating, the ﬁrst day of gestation was
determined by the presence of spermatozoids in vaginal
smears. Pregnant mice (n = 8, at age of 3 months), housed
individually in wood-chip-bedded plastic cages at constant
temperature (25◦C) and humidity (60 ± 5%) with a 12
hours light-dark cycle, were rendered diabetic by ﬁve daily
intraperitoneal injections of streptozotocin (40mg/kg body
weight in 0.1M citrate buﬀer, pH 4.5), starting on day 5 of
gestation [15]. Another group of pregnant mice (n = 8)
were also injected with the vehicle alone and considered as
control groups. The glycemia was followed during gestation
of mice as we described previously [6]. All diabetic dams
included, in this study, had the fasting blood glucose levels
above 1.23g/L. The success rate in obtaining the diabetic
dams was 87.5%. In the litters of diabetic dams, the mean
proportion of hyperglycemic pups at birth was 94.6 ±
3%. Only 12 male oﬀspring born to diabetic dams, which
were hyperglycemic at birth and showed a hyperglycemia
and a hyperinsulinemia at 3 months of age, were selected
and included in the study, since reproductive hormones
have been associated with prevalence, susceptibility, and
severity of obesity and autoimmune disease [16, 17]. The
nonhyperglycemic pups of diabetic mothers were excluded,
as maternal diabetes related to fetal hyperglycemia was the
criterion for the selection of our experimental population
[5]. However, these nonhyperglycemic oﬀspring of diabetic
mothers were not hyperinsulinemic, neither at birth nor
at adulthood. They had normal growth and did not show
any signiﬁcant diﬀerence from the control pups in serum
lipids.
The dams and oﬀspring (after weaning) were fed the
standard laboratory chow. The principles of laboratory
animal care (NIH publication No. 86-23, revised 1985)
were followed, as well as speciﬁc national laws (e.g., the
current version of the German Law on the Protection of
Animals) where applicable. The experimental protocol was
also approved by the Regional Ethical Committee.
2.2. Oral Glucose-Tolerance and Insulin-Tolerance Tests. Oral
glucose-tolerance test (OGTT) was carried out in 12 hyper-
glycemic oﬀspring and 12 control oﬀspring after a 15-h fast.
Brieﬂy, a single dose of glucose was orally administrated
(3g/kg body weight) to the mice. Glycemia was measured
using One Touch ULTRA Glucometer (LifeScan, Johnson
and Johnson, USA), every 5 or 10 minutes for 2 hours
following glucose loading, by cutting oﬀ the tip of tail and
squeezing it gently.
For intraperitoneal insulin-tolerance test (IPITT), a
single dose of insulin (0.5U/kg body weight; Actrapid Novo,
Copenhagen, Denmark) was injected intraperitoneally after
4-h fast and, as in the oral glucose-tolerance tests, glycemia
w a sm e a s u r e de v e r y5o r1 0m i n u t e sf o r2h o u r s ,f o l l o w i n g
insulin injection.
2.3. Blood, Liver, Pancreas, and Epididymal Adipose Tis-
sue Samples. After overnight fasting, animals (3 months-
ages) were anesthetized with pentobarbital (60mg/kg body
weight). Blood was drawn from the abdominal aorta. Serum
was obtained by low-speed centrifugation (1000g × 20 min-
utes) and used for glucose (glucose oxydase method, Beck-
man Instruments, USA) and insulin determination (ELISA
kit, LINCO Research Inc, St. Charles, MO, USA). Pancreas,
epididymal adipose tissue, and livers, after removal, were
weighed then frozen in liquid nitrogen and used for total
RNA extraction.Journal of Obesity 3
2.4.DeterminationofSerumandLiverLipids. Aftertotallipid
extraction, according to the method of Bligh and Dyer [18]
serum or liver triglyceride (TG) and free fatty acids (FFA)
were separated on silica gel by thin layer chromatography
(TLC) and the puriﬁed fractions of FFA and TG were
quantiﬁed by gas liquid chromatography [6, 19].
2.5. Real-Time RT-PCR Quantiﬁcation Assay. Total RNA was
prepared using Trizol reagent (Invitrogen Life Technologies,
Groningen, The Netherlands) according to the manufac-
turer’s instructions. The integrity of RNA was electrophoret-
ically checked by ethidium bromide staining and by the
OD absorption ratio OD260 nm/OD280 nm more than
1.9. One microgram of total RNA was reverse transcribed
with Superscript II RNAse H-reverse transcriptase using
oligo (dT) according to the manufacturer’s instructions
(Invitrogen Life Technologies, France). Real-time PCR was
performed on an iCycler iQ real-time detection system
(Bio-Rad, Hercules, CA, USA) as described elsewhere [6].
Brieﬂy, the ampliﬁcation was done by using SYBR Green
I detection (SYBR Green JumpStart, Taq ReadyMix for
Quantitative PCR, Sigma). Oligonucleotide primers, used
for mRNA analysis, were based on the sequences of mice
gene in GenBank database. The sequence of the reference
gene used for normalization of RT-PCR gene expression data
is the β-actin (forward: 5 -AGAGGGAAATCGTGCGTGAC-
3 ;r ev e rse:5  -CAATAGTGATGACCTGGCCGT-3 ).Allmice
RT-PCR primer sets used to amplify the genes in these
studies are presented in Table 1. All determinations were
performed, in duplicates using two dilutions of each assay to
achieve reproducibility. Results were evaluated by iCycler iQ
software including standard curves, ampliﬁcation eﬃciency
(E), and threshold cycle (Ct). Relative quantitation of mRNA
expression of a large number of signalling factors in diﬀerent
groups was determined using the ΔΔCt method, in which
ΔΔCt = ΔCt of gene of interest-ΔCt of β actin. ΔCt = Ct of
i n t e r e s tg r o u p-C to fc o n t r o lg r o u p .R e l a t i v eq u a n t i t y( R Q )
was calculated as follows: RQ = (1+E)
(−ΔΔCt).
2.6. Statistical Analysis. Results are shown as means ± SEM.
Statistical analysis of data was carried out using STATISTICA
(version 4.1, Statsoft, Paris, France). Data were evaluated
by analysis of variance. Duncan’s Multiple-Range test and
the Student’s t-test were employed for the comparison
betweendiabeticandcontroldams,andtheIRoﬀspringwith
their corresponding controls, respectively. Diﬀerences were
considered signiﬁcant at P<. 05.
3. Results
3.1. Glycemia during Oral Glucose- and Insulin-Tolerance
Tests. During OGTT, the glycemia was higher in the oﬀ-
spring of diabetic dams as compared with their correspond-
ing controls (Figure 1(a)) .T h ea r e au n d e rg l u c o s ec u r v e
during the time of the test was 304.95g/L ∗ 120 minutes for
oﬀspring of diabetic dams, as compared to that of control
oﬀspring which was 175.80g/L ∗ 120 minutes. Two hours
after glucose loading, glycemia was not back to its basal value
Table 1: Gene regions ampliﬁed and their corresponding primer
sequences used for RT-PCR.
Genes ampliﬁed Primer sequences
Mouse RANTES F: 5 -GCAGTCGTGTTTGTCACTCG-3 
R: 5 -TAGGACTAGAGCAAGCGATGAC-3 
Mouse CCR5 F: 5 -GCCTAAACCCTGTCATCTATGC-3 
R: 5 -ATATTTCCCGGCCCTGATAAAAG-3 
Mouse MCP-1 F: 5 -GAGAGCCAGACGGGAGGAAG-3 
R: 5 -TGAATGAGTAGCAGCAGGTGAG-3 
Mouse CD68 F: 5 -TTCAGGGTGGAAGAAAGGTAAAGC-3 
R: 5 -CAATGATGAGAGGCAGCAAGAGG-3 
Mouse IL-6 F: 5 -CCGCTATGAAGTTCCTCTCTGC-3 
R: 5 -ATCCTCTGTGAAGTCTCCTCTCC-3 
Mouse TCRα F: 5 -CCTCTACAGCAGCGTTCTCATCC-3 
R: 5 -GGGTAGGTGGCGTTGGTCTCTTTG-3 
Mouse CD14 F: 5 -GCGTGTGCTTGGCTTGTTG-3 
R: 5 -CAGGGCTCCGAATAGAATCCG-3 
Mouse F4/80 F: 5 -TCCAGCACATCCAGCCAAAGC-3 
R: 5 -CCTCCACTAGCATCCAGAAGAAGC-3 
Mouse TLR-2 F: 5 -CTACAGTGAGCAGGATTCC-3 
R: 5 -CAGCAAAACAAGGATGGC-3 
Mouse TNF-α F: 5 -CTCTTCTCATTCCTGCTTGTGG-3 
R: 5 -AATCGGCTGACGGTGTGG-3 
Mouse SREBP-1c F: 5 -CATCAACAACCAAGACAGTC-3 
R: 5 -CCAGAGAAGCAGAAGAGAAG-3 
Mouse FAT/CD36 F: 5 -TGCTCTCCCTTGATTCTGCTGC-3 
R: 5 -TTTGCTGCTGTTCTTTGCCACG-3 
Mouse AdiponectinF: 5 -GCCGCTTATGTGTATCGCTCAG-3 
R: 5 -GCCAGTGCTGCCGTCATAATG-3 
Mouse Leptin F: 5 -ACACACGCAGTCGGTATCC-3 
R: 5 -GAGTAGAGTGAGGCTTCCAGG-3 
Mouse GlucokinaseF: 5 -AGAAGGCTCAGAAGTTGGAGAC-3 
R: 5 -GGATGGAATACATCTGGTGTTTCG-3 
Mouse Insulin F: 5- TGGCTTCTTCTACACACCCAT-3 
R: 5 -CTCCAGTGCCAAGGTCTGAA-3 
Mouse Glut2 F: 5 -TGTGGTGTCGCTGTTTGTTG-3 
R: 5 -AATGAAGTTTGAGGTCCAGTTGG-3 
Mouse C/EPB-β F: 5 -AGCTGAGCGACGAGTACAAG-3 
R: 5 -AGCTGCTCCACCTTCTTCTG-3 
Mouse Maf-A F: 5 -ATCACTCTGCCCACCATCAC-3 
R: 5 -CGCCAACTTCTCGTATTTCTCC-3 
Mouse Nkx6-1 F: 5 -GGGTCTTCCTCCTCCTCCTC-3 
R: 5 -GGTCTGGTGTGTTTTCTCTTCC-3 
Mouse Pdx-1 F: 5 -CTACTGCCTTCGGGCCTTAG-3 
R: 5 -TTGGAACGCTCAAGTTTGTACC-3 
in hyperglycemic oﬀspring. In response to insulin injection,
the decrease in glycemia was less marked in hyperglycemic
oﬀspring, suggesting decreased insulin sensitivity, that is, an
insulin resistance in these mice (Figure 1(b)). Though, in IR
oﬀspring (hyperglycaemic), glycemia was back to its basal
value, 120 minutes after insulin injection, it remained lower
in controls.4 Journal of Obesity
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Figure 1: (a) Oral glucose-tolerance tests (OGTT). Glycemia during OGTT (3g/kg-body weight) was measured after a 15-h fast, every
5−10 minutes, for 120 minutes following glucose administration. (b) Intraperitoneal insulin-tolerance tests (IPITT). Glycemia during IPITT
(0.5U/kg body weight) was measured after a 4-h fast, every 5−10 minutes, for 120 minutes following insulin injection. ∗P<. 01 signiﬁcant
diﬀerence between control oﬀspring (open triangle) and hyperglycemic oﬀspring (solid triangle). (c) Evolution of the body weight of the
oﬀspring from birth until 3 months of age. Open Square corresponds to control oﬀs p r i n ga n dS o l i dS q u a r et oI Ro ﬀspring. (d) Glycemia and
body weight at 3 months. (e) Serum insulin and insulin mRNA expression in the pancreas. Glycemia, serum insulin, and its mRNA expression
were determined as described in Section 2. The oﬀspring were weighed during the study until the age of 3 months. The dams and the
oﬀspring after weaning were fed the standard laboratory chow. Values are means ± SEM, n = 12 per group of animals. AU: arbitrary units.
3.2. Glycemia, Body Weight, and Serum Insulin Concentra-
tion and Its mRNA Expression in Pancreas. There was no
signiﬁcant diﬀerence in the body weight between control
and IR oﬀspring, from their birth until 3 months of age
(Figure 1(c)). However, the IR oﬀspring were hyperglycemic
and hyperinsulinemic and expressed high level of insulin
transcript compared with their controls (Figures 1(d) and
1(e)).
3.3. Maf-A, Nkx6-1, Pdx-1, C/EBP-β,G l u t2 ,a n dG l u c o k i n a s e
mRNA Expression in the Pancreas. It is well known that
glucose stimulates insulin release [9]. Moreover, Glut2
and glucokinase (GK) are implicated in the regulation of
glucose metabolism gene transcription in β-cells [20, 21].
Besides, some factors like Pdx-1, Nkx6.1, and Maf-A are
required for insulin gene transcription [7, 8]. Assessment of
the beta-cell functionality may need hyperglycemic clamp
study and glucose-tolerance test. As we have performed
the glucose-tolerance test and assessed some major insulin
genetranscriptionfactors,wethereforeexaminedtherelative
quantitative expression of mRNA encoding for these factors
in the pancreas and assessed, in the β-cells, the levels
of Glut2 and glucokinase mRNA. Indeed, while C/EBP-β
mRNA was undetectable, IR oﬀspring expressed higher Maf-
A, Nkx6-1, and Pdx-1 transcripts than their corresponding
controls (Figure 2(a)). Glut2 and GK mRNA expressions
were downregulated in IR oﬀspring compared to controls
(Figure 2(b)).Journal of Obesity 5
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Figure 2: Maf-A, Nkx6-1, Pdx-1, and C/EBP-β (a),G l u t 2a n dG K(b) mRNA expression in the pancreas of IR and control oﬀspring.T h e
expression of mRNA was quantitatively analyzed by employing real-time RT-PCR as described in Section 2. AU: arbitrary units. (c) Serum
and hepatic triglyceride (TG) and free fatty acids (FFA) in IR and control oﬀspring. The lipids were determined in serum and liver as described
in Section 2. Values are means ± SEM, n = 12 per group of animals.6 Journal of Obesity
3.4. Serum and Hepatic TG and FFA Concentrations. Insulin
resistance has been associated with hyperlipidemia [22].
I nd eed,inthep r ese ntstud y ,IRo ﬀspringhighlyaccumulated
of TG and FFA in their liver and serum as compared to
control animals (Figure 2(c)).
3.5. Adiposity, Adiponectin, Leptin, TNF-α,a n dI L - 6m R N A
Expression in Epididymal Adipose Tissue. Obesity has been
linked to high adiposity and hyperlipidemia [6, 23]. More-
over, it has been reported that chronic inﬂammation in fat
plays crucial role in the development of insulin resistance
[22]. Therefore, we assessed the weight of epididymal
adipose tissue as well as the obesity-related parameters such
as adiponectin and leptin and proinﬂammatory markers
(TNF-α a n dI L - 6 ) .I n d e e d ,I Ro ﬀspring exhibited reduced
epididymal adipose tissue mass than the control oﬀspring
(Figure 3(a)). The quantity of epididymal adipose tissue
was positively correlated with the expression of mRNA of
adiponectin (R2 = 0.87 in controls oﬀspring versus R2 =
0.90 in IR oﬀspring) and leptin (R2 = 0.85 in controls
oﬀspring versus R2 = 0.95 in IR oﬀspring) (Figures 3(a) and
3(b)). Conversely, IR oﬀspring showed increased expression
of proinﬂammatory markers which are IL-6 and TNF-α in
their epididymal adipose tissue (Figure 3(c)).
3.6. Liver Weight and FAT/CD36, SREBP-1c, TNF-α and IL-6,
mRNA Expression in the Liver. While the IR oﬀspring exhib-
ited reduced epididymal adipose tissue mass, they showed
higher liver weight than that of the controls (Figure 3(d)).
Consequently, the liver of IR oﬀspring exhibited features
of steatosis. Furthermore, FAT/CD36 is actively implicated
in the uptake of lipids and, hence, may contribute to high
lipid contents in the liver. Moreover, chronic inﬂammation
has been reported as a link between insulin resistance and
obesity, associated with lipid accumulation [22, 24]. We
therefore examined the expression of lipid transporters and
some proinﬂammatory markers in liver. Indeed, while the
expression of FAT/CD36 mRNA was upregulated, that of
SREBP-1c mRNA was downregulated in the liver of IR
oﬀspring compared to controls (Figure 3(e)). There was no
signiﬁcantdiﬀerenceinexpressionofIL-6mRNA(1.00±0.12
versus 1.11 ± 0.14) and TNF-α mRNA (1.00 ± 0.10 versus
0.90 ±0.15) in the liver of both groups of mice.
3.7. CD14, CD68, F4/80, TCRα, TLR-2, MCP-1, RANTES,
and CCR5 mRNA Expression in Epididymal Adipose Tissue.
Macrophages and T cells accumulation in adipose tissue
characterized the inﬂammation in obesity [12, 14]. Since
inﬂammation has appeared as a link between insulin resis-
tance and obesity and diabetes [24], we examined the
level of macrophage and T cell markers in the epididymal
adipose tissue of insulin-resistant oﬀspring. While none
of the mRNA expression of F4/80, MCP-1 (inﬁltrated
macrophages’ marker), TCRα, RANTES, and CCR5 (inﬁl-
trated T cells’ markers) was detectable from all animal
groups,IRoﬀspringexpressedhighlevelofCD14,CD68,and
TLR-2mRNAintheirepididymaladiposetissueascompared
to controls (Figures 4(a) and 4(b)).
4. Discussion
High-fat diet feeding induces obesity and metabolic disor-
ders in rodents [3]. However, this dietary intervention is not
well standardized. The question which type of high-fat diet
is best to the model of human metabolic alterations remains
unanswered. On the other hand, the use of monogenic
models (such as the ob/ob mouse or the Zucker-(fa/fa) fatty
rat) or pharmacologically-induced obesity models (such
as the gold-thioglucose mouse) has raised some problems
concerning the interpretation of the observed eﬀects. The
question of whether the results obtained arise from the
obese phenotype or the model’s genetic/pharmacological
background is diﬃcult to solve completely. These obser-
vations prompt researchers to generate obesity in animals
by using fat-enriched (high-fat) diet strategies for several
years now. Indeed, several studies have revealed that high-
fat diets promote hyperglycemia and whole body insulin
resistance, and their eﬀects on target organs have been
examined. Based on this experience, it is generally accepted
that high-fat diets can be used to generate a valid rodent
model for the metabolic syndrome with insulin resistance
and altered beta-cell function [25–27]. However, the real
diﬃculty is the deﬁnition of the term “high-fat diet” itself
and the standardization of the exact fat content and fat
composition of the diets. Various high-fat diets have been
used with relative fat fractions between 20% and 60%
energy as fat, and the basic fat component varies between
animal-derived fats [3]. Consequently, all these diets are
summarized under the term high-fat diets in the literature.
This has inevitably led to a considerable variability in the
results reported. In the present study, we propose a new
model of pathological insulin resistance associated with
maternal diabetic pregnancy. Therefore, the present study
is designed to shed light on the pathophysiological model
of insulin resistance, related to diabetic pregnancy in mice.
The insulin-resistant (IR) oﬀspring, in our laboratory, have
been obtained from pregnant animals which were rendered
diabetic by the administration of streptozotocin [4–6]. As
far as the model design is concerned, we would like to
mention that maternal streptozotocin administration before
pregnancy aﬀects fertility and impairs embryo development
during the preimplantation period [28]. However, like in the
present study, the induction of diabetes by streptozotocin
injection on day 5 of gestation has no eﬀect on embryo
development [29]. Moreover, we induced diabetes during
the second half of the ﬁrst trimester of pregnancy with ﬁve
low doses of streptozotocin starting on day 5 of gestation to
mimic type 1 diabetic pregnancy, following a T lymphocyte-
dependent process [30, 31]. Moreover, the administration
of low doses of streptozotocin to rodents represents a good
model of diabetes development, and this is for several
reasons: (i) islet lesions in this experimental model resemble
to those of human insulitis, with a predominance of CD8+
T cells [30], (ii) the animals used are normal and do not
have an underlying immune abnormalities like BB rat, being
lymphopenic with few peripheral CD8+ T cells [32], and
NOD mice which have systemic immune abnormalities [33],
(iii) the onset of diabetes is controlled, and (iv) the Th1/Th2Journal of Obesity 7
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Figure 3:Relativeepididymaladiposetissueweight (a)andadiponectinandleptin(b),andTNF -αandIL-6 (c)mRNAexpressioninepididymal
adipose tissue. Relative liver weight (d) and FAT/CD36 and SREPB-1c mRNA expression in liver (e) of IR and control oﬀspring. The liver and
epididymal adipose tissue weights are expressed as milligrams (mg) of the tissue per grams (g) of body weight of mice. The expression of
mRNA was quantitatively analyzed by employing real-time RT-PCR as described in Section 2. Values are means ± SEM, n = 12 per group of
animals. AU: arbitrary units. The quantity of epididymal adipose tissue was positively correlated with the mRNA expression of adiponectin
and leptin two obesity-related parameters; R2 = coeﬃcient of correlation between the mass of epididymal adipose tissue and the level of the
expression of adipokines (adiponectin and leptin) in each group of animals.
dichotomy can be observed during diabetes in these animals
[30, 34]. These IR oﬀspring of diabetic dams showed, after
OGTT, a high hyperglycemia compared with control oﬀ-
spring. Moreover, the IPITT demonstrated decreased insulin
sensitivity in these mice. These observations conﬁrmed a real
insulin resistance in these oﬀspring [35, 36].
Theﬁrstandforemostquestionishowthehyperglycemia
modulates pancreatic β-cell functions. We observed that
IR mice born to diabetic dams had higher serum insulin
levelsandpancreaticinsulintranscriptsthancontrolmice,in
accordance with our previous observations [5, 6]. Pancreatic
β-cells produce and store insulin in response to physiological
demand, and hyperglycemia, within 15 minutes, results
in the activation of a complex network of intracellular
signalling pathways that trigger insulin release [37]. The
hyperinsulinemic state of IR oﬀspring may be due to high
expression of the major insulin gene transcription factors
which are Pdx-1, Maf-A, and Nkx6 in their pancreas [38].
Indeed, other investigators have shown that the deletion of
Pdx-1 gene in the pancreas results in abnormally low insulin
concentrations [39]. In our study, the glucose-induced
hyperinsulinemia does not seem to be mediated by C/EBP-
β as the expression of this repressor of insulin gene was not
signiﬁcantly altered in both groups of animals. Pancreatic
β-cell function is associated to glucokinase activity [21].
IR mice exhibited low expression of glucokinase and Glut2
mRNA in the pancreas and this phenomenon might be
responsible for impaired glucose transport and metabolism,
thus contributing to high glucose concentration in these
animals, as suggested by Ahlgren et al. [39] that reduced8 Journal of Obesity
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Figure 4: The mRNA expression of CD14, CD68, F4/80, RANTES, CCR5, MCP-1, TCRα (a), and TLR-2 (b) in epididymal adipose tissue of IR
and control oﬀspring. The expression of mRNA was quantitatively analyzed by employing real-time RT-PCR as described in Section 2. Values
are means ± SEM, n = 12 per group of animals. AU: arbitrary units.
Glut2 levels lead to hyperglycemia. Indeed, glucose has been
shown to stimulate insulin release and the transcription
of insulin gene and translation of the nascent mRNA in
pancreatic β-cells [9]. Several investigators have interestingly
demonstrated both in vivo and in primary culture in
vitro, that the eﬀect of glucose on glycolytic and lipogenic
genes in GK knockout hepatocytes is lost because of the
impaired ability of these cells to eﬃciently metabolize
glucose [40]. Moreover, other investigators have shown that
downregulation of SREBP-1c expression induces a markedly
decrease in Glut2 expression [41]. Thus, we can state that
the hyperglycemic state in IR oﬀspring might be also due to
the marked decreased expression of GK and Glut2, as these
animals, in addition, exhibited low expression of SREBP-
1c which may contribute to decreased level of Glut2 [41].
However, it is useful to specify that this hyperglycemia in IR
mice might also be due to low insulin sensitivity in target
peripheral organs.
While the IR oﬀspring exhibited reduced epididymal
adipose tissue mass, they showed increased liver weight
than the control oﬀspring and, consequently, the liver of IR
oﬀspring showed features of steatosis. This could, at least in
part, account for their similar body weight despite reduced
epididymal adipose tissue mass in IR oﬀspring which also
abundantly accumulated FFA and TG [5, 6]. It has been well
established by several studies that diabetes mellitus induces
hyperlipidemia in mothers and in their obese oﬀspring [5,
42, 43]. In diabetic rats, high levels of triglyceride in mater-
nal circulation may create a steep concentration gradient
across the placenta, which accelerates their transport and
deposition in fetal tissues [43]. This hypertriglyceridemia
persists with age and has been linked to the development
of insulin resistance and hyperlipogenesis [44]. Besides, IR
oﬀspring exhibited high levels of CD36/FAT which will again
participateinhighuptakeoflipidsbyliverandwillultimately
contribute to liver steatosis in these animals. Furthermore,
the mRNA of SREBP-1c is downregulated in IR oﬀspring.
SREBP-1c controls the transcription of lipogenic genes.
Hence, a high accumulation of TG and FFA in the liver, due
tohighexpressionofFAT/CD36,mightberesponsibleforthe
low expression of SREBP-1c in these animals. On the other
hand, some authors have demonstrated, in vivo and in vitro,
that hepatic GK is required for synergistic action of SREBP-
1c and ChREBP on glycolytic and lipogenic gene expression
[40]. Other investigators have observed altered expression
and activity of SREBP-1c in GK-knockout mice [45]. As the
IR mice, in our study, expressed low GK, we can state that
reduced expression of SREBP-1c might be due to the low
expression of glucokinase mRNA.
Adipokines, secreted by adipose tissue, are required
for a number of metabolic processes [46]. In this study,
adiponectin and leptin levels were positively correlated with
the epididymal adipose tissue mass which decreased in IR
oﬀspring. These observations are in accordance with our
previousresultsinmacrosomicinfantsofgestationaldiabetic
women [47]. Furthermore, Guerre-Millo et al. [48]h a v e
also shown that high-fat diet-fed mice exhibited higher
glucose levels and lower adiponectin concentrations than
the standard diet animals. Hence, reduced adiponectin will
again contribute to insulin resistance as this adipokine,
an anti-inﬂammatory agent, has been shown to enhance
insulin sensitivity [49, 50]. In our study, IL-6 and TNF-
α mRNA are upregulated in the epididymal adipose tissue
of IR oﬀspring. It has been recently shown that adipose
tissue, during insulin-resistant state, secrete IL-6 and TNF-
α [14]. Moreover, high levels of TNF-α and IL-6 may also
downregulate the expression of adiponectin [51].
In IR oﬀspring, increased IL-6 might not only diminish
insulin sensitivity by suppressing insulin signal transduction
but also interfere with anti-inﬂammatory eﬀect of insulin,
and might favour inﬂammation during insulin-resistance
state, as demonstrated by Dandona et al. [24]. Furthermore,Journal of Obesity 9
IL-6 has been shown to be one of the mediators of
hyperinsulinemic state [52]. It is interesting to mention that
10%−35% of the body’s basal circulating IL-6 is derived from
adipose tissue and a positive correlation has been found
between insulin resistance and circulating IL-6 [24]. Thus,
we can state that hyperglycemia may be one of the factors
implicated in IL-6 expression [24].
As far as inﬂammation in adipose tissue is concerned,
we observed that CD14 and CD68 mRNA expression, but
not F4/80, was upregulated in epididymal adipose tissue
of IR oﬀspring. These observations suggested that the
adipocytes seemed to be diﬀerentiated into macrophage-
like cells, as they expressed upregulated transcripts of CD14
and CD68 antigens, generally expressed by macrophages.
However, there was no peripheral macrophages inﬁltra-
tion into epididymal adipose tissue, as the expression of
F4/80, a true macrophage marker, was downregulated. Our
results are in close agreement with those of Khazen et al.
[53] who have reported that murine and human adipose
tissue express CD14 and CD68, but not F4/80, both at
protein and mRNA levels. Besides, Cousin et al. [54]h a v e
demonstrated that preadipocytes can be diﬀerentiated into
macrophage-like cells which are stained with MOMA-2, a
marker of monocyte-macrophage lineage, but are negative
for F4/80. Besides, the lack of expression of MCP-1, a mono-
cytes/macrophages chemoattractant, provides an additional
argument for the absence of macrophages in epididymal
adipose tissue of these animals. Moreover, it has been
reported that RANTES and its receptor CCR5 are expressed
principally on inﬁltrated T cells in adipose tissue during
insulin resistance in high-fat diet-fed animals [14]. In our
study, we could not detect both RANTES and CCR5 mRNA
in epididymal adipose tissue of the IR mice. Furthermore,
we did not observe the expression of TCR-alpha mRNA,
suggesting that T cells are not inﬁltrated in epididymal
adipose tissue of these mice. These ﬁndings corroborate the
study of Xu et al. [22] who did not observe inﬁltration of T
cellsinwhiteadiposetissueofbothgeneticandhigh-fatdiet-
induced mouse models of insulin resistance.
In vitro diﬀerentiated adipocytes have been shown to
express TLR-2 [55] and the polymorphism of TLR-2 gene
signiﬁcantly correlates with a higher risk of insulin resistance
[56]. Weobserved thatTLR-2mRNAexpression increased in
epididymal adipose tissue of IR mice and these observations
corroborate the report of Murakami et al. [36] who have
shown that the adipocytes, in rats fed a high-fat diet,
coexpress TNF-α and TLR-2, and these adipocytes do not
express F4/80. Besides, these authors [36]h a v es u g g e s t e d
that adipocytes coexpressing TNF-α and TLR-2 might be
“pathological” cells in fat tissue, promoting the development
of insulin resistance as seen in metabolic syndrome. Finally,
we observed that IR oﬀspring exhibited a high level of FFA in
serum and liver. Murakami et al. [36] have also shown that
increased FFA level may activate inﬂammatory pathway in
adipocytes, and TLR-2 seems to contribute to this pathway
by inducing TNF-α production.
Therefore, the novelty of our study is that, in this model
of insulin resistance without obesity, the inﬂammatory state
of epididymal adipose tissue of IR oﬀspring is intrinsic
to this organ which cells seemed to be diﬀerentiated into
macrophage-like cells, but not because of the macrophages
or T cell inﬁltration.
5. Conclusion
To sum up, our study demonstrates that the hyperinsuline-
mia, observed in IR oﬀspring of diabetic dams, appears as a
pathological model of insulin resistance which is associated
with altered expression of genes of insulin transcription
factors and glucose metabolism-related enzymes. Our study
will help understand the mechanisms of insulin resistance in
oﬀspring, born to diabetic mothers, as several studies have
shown that these oﬀspring are prone to develop metabolic
syndrome [5, 44].
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